Tag: Keystone Heart
Venus Medtech to buy cerebral protection device company Keystone Heart
Venus Medtech has signed an agreement to acquire Keystone Heart, a privately-held medical device com...
First patient enrolled in phase II of REFLECT study of TriGuard 3
Keystone Heart announced the launch of phase II of the REFLECT trial, which is evaluating the ne...
Keystone Heart accelerate trials for third-generation of its TriGuard device
Keystone Heart has announced plans to initiate clinical trials for a new, advanced version of it...
New brain lesions are found in 94% of patients following TAVI
A study published in the American Journal of Cardiology indicates that 94% of patients have evid...
TriGuard cerebral protection associated with significant improvements in brain protection in TAVI patients
Preliminary real-world findings, presented at PCR London Valves (18–20 September, London, UK), i...
